BioCentury
ARTICLE | Financial News

Blend raises $16 million in series B

December 19, 2012 2:15 AM UTC

Blend Therapeutics Inc. (Watertown, Mass.) raised $16 million in a series B round led by existing investor NanoDimension. Existing investors Flagship Ventures and New Enterprise Associates also participated. Additionally, Blend hired Mark Iwicki as president, CEO and a director. He was formerly CEO of the Sunovion Pharmaceuticals Inc. subsidiary of Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506; Osaka:4506). ...